CFO Role to Transition at RB

Reckitt Benckiser (RB) announced that Liz Doherty, its CFO, is stepping down from the role, and Adrian Hennah, currently CFO with Smith & Nephew, has been appointed as the new CFO for RB.

Commenting, Rakesh Kapoor, CEO, said, “I am pleased to welcome Adrian Hennah as CFO. His global experience, especially in the health care industry, will be very valuable as we execute our strategy of extending our health and hygiene powerbrands internationally, with a particular focus on emerging markets. I want to thank Liz for her excellent support over the past two years. She has strengthened our finance function around the world, and has been instrumental in helping to ensure a smooth CEO transition for the business. However, Liz and I have agreed that RB’s and her way of working are not as well matched as either of us would like, and now is the right time for her to move to a new opportunity.”

Doherty will stay with the business until March 2013 and Hennah will join at end December 2012. This overlap will help ensure a smooth transition during the year-end period.

Hennah has held his role as CFO of Smith & Nephew plc since 2006 and has been instrumental in helping the business to focus on improving efficiency in maturing markets and growth in emerging markets, especially China. From 2002 to 2006, he was CEO of Invensys, and he spent most of his earlier career (1984-2002) at GlaxoSmithKline plc (GSK), including in the roles of SVP finance and operations GSK research and development, CFO of GlaxoWellcome USA and finance director Glaxo UK, in addition to general management. Hennah also worked at PWC (then Price Waterhouse) both in audit and consultancy from 1980-1984, and from 1978-1980 worked in Stadtsparkasse Koeln, the German regional bank. He also is a non-executive director of Reed Elsevier.


More in News